What is the outlook for Medicare Advantage Supplemental Benefits and Social Determinants of Health Initiatives under the Biden administration in 2021 and beyond? This session examines the Biden health policy agenda; the prognosis for Medicare Advantage Supplemental Benefits and Social Determinant of Health Initiatives during the coming year; developments in the SDOH arms race and what CMS policy can be anticipated during 2021 in this arena.

John Gorman, a nationally recognized health policy expert in areas including Medicare, Medicaid, ACA and SDOH, provides his significant insights for the coming year. John is Founder and Chairman of Nightingale Partners, a Qualified Opportunity Zone Fund and advisory firm connecting capital to payers and care providers to the medically underserved. Nightingale endeavors to improve the quality of care and reduce unnecessary health care expenditures for impactable, high-utilizers through advanced technology, locally-curated social services providers, and innovative financing to address Social Determinants of Health (SDOH). 

Nightingale Partners’ John Gorman explores Nightingale’s approach and how Opportunity Zone Funds can partner with Medicare Advantage and Medicaid plans to invest in Social Determinants of Health initiatives.